van Veggel, B. A. M. H., van der Wekken, A. J., Paats, M. S.
, Hendriks, L. E. L., Hashemi, S. M. S., Daletzakis, A., van den Broek, D., Bosch, L. J. W., Monkhorst, K., Smit, E. F., & de Langen, A. J. (2024).
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer.
Cancer,
130(5), 683-691.
https://doi.org/10.1002/cncr.35090